Focus Partners Advisor Solutions’s Edwards Lifesciences EW Stock Holding History

Focus Partners Advisor Solutions’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.05M	Sell	13,093 -1,380	-10%	-$114K	0.01%	543
2025 Q4	$1.23M	Buy	14,473 +73	+0.5%	+$5.99K	0.02%	438
2025 Q3	$1.17M	Buy	14,400 +5,512	+62%	+$431K	0.01%	472
2025 Q2	$695K	Buy	8,888 +1,499	+20%	+$112K	0.01%	560
2025 Q1	$535K	Buy	7,389 +3,195	+76%	+$229K	0.01%	570
2024 Q4	$310K	Sell	4,194 -3,979	-49%	-$278K	0.01%	597
2024 Q3	$539K	Sell	8,173 -1,682	-17%	-$122K	0.01%	435
2024 Q2	$910K	Buy	+9,855	New	+$873K	0.02%	261

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Focus Partners Advisor Solutions's EW Position: Q1 2026 in Review

Focus Partners Advisor Solutions reduced its Edwards Lifesciences (EW) stake by 9.5% in Q1 2026, selling an estimated $114K and leaving 13,093 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #543.

Focus Partners Advisor Solutions first reported a position in EW in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.23M in Q4 2025. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

Focus Partners Advisor Solutions held 13,093 shares of Edwards Lifesciences worth $1.05M as of Q1 2026.
Focus Partners Advisor Solutions sold 1,380 Edwards Lifesciences shares in Q1 2026, an estimated $114K.
Edwards Lifesciences made up 0.01% of Focus Partners Advisor Solutions's portfolio in Q1 2026, its #543 holding.
Focus Partners Advisor Solutions first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 8 quarters since.
Focus Partners Advisor Solutions's Edwards Lifesciences position peaked at $1.23M in Q4 2025.
1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.